NEW YORK (GenomeWeb) – LexaGene announced today that it has entered an agreement with a group of underwriters led by Canaccord Genuity to purchase up to 5 million units of stock at a price of $1.00 per unit, for gross proceeds of C$5.0 million ($3.7 million).

Each unit will consist of one common share of the company and one half of one common share purchase warrant, with each share entitling the holder to acquire one share at a price of C$1.30 until June 22, 2021.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.